SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-028352
Filing Date
2024-07-18
Accepted
2024-07-18 16:35:32
Documents
16
Period of Report
2024-07-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41219
2 ex10-1.htm EX-10.1 560227
3 ex99-1.htm EX-99.1 24213
4 ex99-1_001.jpg GRAPHIC 39465
  Complete submission text file 0001493152-24-028352.txt   945521

Data Files

Seq Description Document Type Size
5 evfm-20240714.xsd EX-101.SCH 3009
6 evfm-20240714_lab.xml EX-101.LAB 34916
7 evfm-20240714_pre.xml EX-101.PRE 22785
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3740
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 241125157
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)